view article

Figure 3
Crystals of AbALR with nine different shapes observed from 39 conditions in initial crystallization trials. (a) 2% Tascimate pH 5.0, 0.1 M sodium citrate tribasic dihydrate pH 5.6, 16% PEG 3350 (PEG/Ion 2 condition 32). (b) 0.02 M magnesium chloride hexahydrate, 0.1 M HEPES pH 7.5, 22% poly(acrylic acid sodium salt) 5100 (Index condition 59). (c) 25% PEG 3350, 10%(v/v) 2-methyl-2,4-pentanediol, 200 mM lithium sulfate, 100 mM imidazole–HCl pH 6.5 (Wizard Precipitant Synergy condition 142). (d) 0.17 M ammonium sulfate, 25.5% PEG 4000, 15% glycerol (Crystal Screen Cryo condition 30). (e) 0.1 M magnesium formate dihydrate, 15% PEG 3350 (Index condition 92). (f) 8% Tascimate pH 5.0, 20% polyethylene glycol 3350 (PEG/Ion 2 condition 12). (g) 0.2 M potassium sodium tartrate tetrahydrate, 20% PEG 3350 (Index condition 86). (h) 0.17 M ammonium acetate, 0.085 M sodium acetate trihydrate pH 4.6, 25.5% PEG 4000, 15% glycerol (Crystal Screen Cryo condition 10). (k) 3.5 M sodium formate, 0.1 M sodium acetate trihydrate pH 4.6 (SaltRX condition 30). The scale bars represent 0.01 mm.

Journal logoSTRUCTURAL BIOLOGY
COMMUNICATIONS
ISSN: 2053-230X
Follow Acta Cryst. F
Sign up for e-alerts
Follow Acta Cryst. on Twitter
Follow us on facebook
Sign up for RSS feeds